BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/11/2025 7:47:42 AM | Browse: 132 | Download: 751
 |
Received |
|
2025-02-02 11:02 |
|
Peer-Review Started |
|
2025-02-02 11:02 |
|
First Decision by Editorial Office Director |
|
2025-03-21 22:51 |
|
Return for Revision |
|
2025-03-21 22:51 |
|
Revised |
|
2025-04-02 14:50 |
|
Publication Fee Transferred |
|
2025-04-07 01:23 |
|
Second Decision by Editor |
|
2025-05-26 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-05-26 07:02 |
|
Articles in Press |
|
2025-05-26 07:02 |
|
Edit the Manuscript by Language Editor |
|
2025-06-13 00:44 |
|
Typeset the Manuscript |
|
2025-07-07 06:41 |
|
Publish the Manuscript Online |
|
2025-07-11 07:47 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Kushenol I combats ulcerative colitis via intestinal barrier preservation and gut microbiota optimization
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xu-Dong He, Min Li, Xiang-Duo Zuo, Hao-Yu Ni, Yu-Xin Han, Yun-Kai Hu, Jie Yu and Xing-Xin Yang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
No. 82060707 |
| National Natural Science Foundation of China |
No. 82104381 |
| Application and Basis Research Project of Yunnan China |
No. 202201AW070016 |
| Application and Basis Research Project of Yunnan China |
No. 202407AB110018 |
| Engineering Research Center of Yunnan Education Department |
No. 2022YGG03 |
| Open Research Fund Program of Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment |
No. 2019DG016 |
|
| Corresponding Author |
Xing-Xin Yang, Professor, College of Pharmaceutical Science, Yunnan University of Chinese Medicine, No. 1076 Yuhua Road, Kunming 650500, Yunnan Province, China. yxx78945@163.com |
| Key Words |
Kushenol I; Ulcerative colitis; Gut microbiota; Sophora flavescens Aiton; Network pharmacology; Intestinal integrity |
| Core Tip |
Kushenol I (KSCI) from Sophora flavescens shows promise for treating ulcerative colitis (UC). Network pharmacology reveals 192 potential targets, including protein kinase B, NOD-like receptor thermal protein domain associated protein 3, Toll-like receptor 4, phosphoinositide 3-kinase and forkhead box O1. In UC mice, KSCI alleviates symptoms, reduces pro-inflammatory cytokines, enhances anti-inflammatory activity, and inhibits the activation of key signaling pathways. It also exerts antioxidant effects, repairs intestinal barrier damage, and modulates the gut microbiota. Additionally, KSCI regulates T-cell balance. These findings highlight KSCI’s multi-target mechanism offering potential as a therapeutic agent for UC. |
| Publish Date |
2025-07-11 07:47 |
| Citation |
He XD, Li M, Zuo XD, Ni HY, Han YX, Hu YK, Yu J, Yang XX. Kushenol I combats ulcerative colitis via intestinal barrier preservation and gut microbiota optimization. World J Gastroenterol 2025; 31(26): 105656
|
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i26/105656.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i26.105656 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
